The clinicopathological significance of SEMA3A expression in HNSCC prompted us to further dissect the possible biological roles of SEMA3A in cancer progression by gain-of-function assays and genetic approaches. This evidence concerns the gene SEMA3A and head and neck squamous cell carcinoma.